General Information of the Compound
| Compound ID |
CP0041805
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(E)-resveratrol
Show/Hide
|
||||||||||||||||||
| Synonyms |
(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol
CU-01000001503-3
Cis-resveratrol
KSC-10-164
KUC104385N
PREVENTION 8 (RESVERATROL)
R 5010
RM-1812
Resveratrol
Resveratrol-3-sulfate
Resvida
SRT 501
SRT-501
Trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene
Trans-3,4′,5-Trihydroxystilbene
Trans-3,4',5-trihydroxystilbene
Trans-resveratrol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C14H12O3
|
||||||||||||||||||
| Molecular Weight |
228.247
|
||||||||||||||||||
| Canonical SMILES |
Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+
Show/Hide
|
||||||||||||||||||
| InChIKey |
LUKBXSAWLPMMSZ-OWOJBTEDSA-N
|
||||||||||||||||||
| CAS |
501-36-0
31100-06-8
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00918, Amine oxidase [flavin-containing] A
Protein ID: PT01546, ATP-dependent translocase ABCB1
Protein ID: PT01002, Cytochrome P450 1A2
Protein ID: PT01049, Cytochrome P450 2C19
Protein ID: PT00905, Cytochrome P450 2C9
Protein ID: PT00986, Cytochrome P450 3A4
Protein ID: PT00886, Estrogen receptor
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Protein ID: PT01718, Nitric oxide synthase, inducible
Protein ID: PT04367, Nuclear factor erythroid 2-related factor 2
Protein ID: PT04197, Ornithine decarboxylase
Protein ID: PT01242, Polyunsaturated fatty acid 5-lipoxygenase
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Protein ID: PT02149, Transient receptor potential cation channel subfamily A member 1
Protein ID: PT02148, Transient receptor potential cation channel subfamily A member 1
Cell Viability or Cytotoxicity Assay
Clinical Information about the Compound
Drug 1 ( Resveratrol )
| Drug Name | Resveratrol | ||
|---|---|---|---|
| Company | Sirtris Pharma | ||
| Indication | |||
| Target(s) | |||